708 related articles for article (PubMed ID: 27129615)
41. Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting function.
López-Albaitero A; Mailliard R; Hackman T; Andrade Filho PA; Wang X; Gooding W; Ferrone S; Kalinski P; Ferris RL
J Immunother; 2009 Jun; 32(5):465-73. PubMed ID: 19609238
[TBL] [Abstract][Full Text] [Related]
42. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8
Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T
Front Immunol; 2018; 9():2775. PubMed ID: 30542351
[TBL] [Abstract][Full Text] [Related]
43. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
[TBL] [Abstract][Full Text] [Related]
44. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
45. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
[TBL] [Abstract][Full Text] [Related]
46. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
Schlecht G; Leclerc C; Dadaglio G
J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742
[TBL] [Abstract][Full Text] [Related]
47. Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells.
Katakam AK; Brightbill H; Franci C; Kung C; Nunez V; Jones C; Peng I; Jeet S; Wu LC; Mellman I; Delamarre L; Austin CD
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14664-9. PubMed ID: 26561586
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.
Moret FM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheumatol; 2015 Mar; 67(3):637-44. PubMed ID: 25469671
[TBL] [Abstract][Full Text] [Related]
49. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
[TBL] [Abstract][Full Text] [Related]
50. Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor.
Baxevanis CN; Voutsas IF; Tsitsilonis OE; Gritzapis AD; Sotiriadou R; Papamichail M
J Immunol; 2000 Apr; 164(7):3902-12. PubMed ID: 10725753
[TBL] [Abstract][Full Text] [Related]
51. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.
Yu CI; Becker C; Wang Y; Marches F; Helft J; Leboeuf M; Anguiano E; Pourpe S; Goller K; Pascual V; Banchereau J; Merad M; Palucka K
Immunity; 2013 Apr; 38(4):818-30. PubMed ID: 23562160
[TBL] [Abstract][Full Text] [Related]
52. Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signaling.
Ahmed KA; Wang L; Munegowda MA; Mulligan SJ; Gordon JR; Griebel P; Xiang J
J Leukoc Biol; 2012 Aug; 92(2):289-300. PubMed ID: 22544940
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
54. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
Zarling AL; Johnson JG; Hoffman RW; Lee DR
J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
[TBL] [Abstract][Full Text] [Related]
55. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
56. CD154+ CD4+ T-cell dependence for effective memory influenza virus-specific CD8+ T-cell responses.
Olson MR; Seah SG; Edenborough K; Doherty PC; Lew AM; Turner SJ
Immunol Cell Biol; 2014 Aug; 92(7):605-11. PubMed ID: 24777309
[TBL] [Abstract][Full Text] [Related]
57. Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.
Ramadan G; Konings S; Kurup VP; Keever-Taylor CA
Cytotherapy; 2004; 6(3):223-34. PubMed ID: 15203979
[TBL] [Abstract][Full Text] [Related]
58. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
[TBL] [Abstract][Full Text] [Related]
59. Phenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans Cells.
Fehres CM; Bruijns SC; Sotthewes BN; Kalay H; Schaffer L; Head SR; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
PLoS One; 2015; 10(11):e0143519. PubMed ID: 26605924
[TBL] [Abstract][Full Text] [Related]
60. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]